Click here to get full coverage on Short Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Expands By 27.4% - MarketBeat

Short Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Expands By 27.4%  MarketBeat

Short Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Expands By 27.4% - MarketBeat

Click here to get full coverage on Industries Limited (DTIL) Quarterly Results Are Out - Federal Reserve Announcements & Fast Growing Investment Ideas - bollywoodhelpline.com

Industries Limited (DTIL) Quarterly Results Are Out - Federal Reserve Announcements & Fast Growing Investment Ideas  bollywoodhelpline.com

Industries Limited (DTIL) Quarterly Results Are Out - Federal Reserve Announcements & Fast Growing Investment Ideas - bollywoodhelpline.com

Click here to get full coverage on Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha

Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL)  Seeking Alpha

Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha

Click here to get full coverage on Precision BioSciences (DTIL) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance

Precision BioSciences (DTIL) Moves 11.1% Higher: Will This Strength Last?  Yahoo Finance

Precision BioSciences (DTIL) Moves 11.1% Higher: Will This Strength Last? - Yahoo Finance

Click here to get full coverage on Insider Purchase: Director at $DTIL Buys 3,000 Shares - Quiver Quantitative

Insider Purchase: Director at $DTIL Buys 3,000 Shares  Quiver Quantitative

Insider Purchase: Director at $DTIL Buys 3,000 Shares - Quiver Quantitative

Click here to get full coverage on Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants - Business Wire

Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants  Business Wire

Precision BioSciences Announces $75 Million Offering of Common Stock, Pre-Funded Warrants and Warrants - Business Wire

Click here to get full coverage on Brown Melinda buys $6846 in Precision BioSciences (DTIL) - Investing.com

Brown Melinda buys $6846 in Precision BioSciences (DTIL)  Investing.com

Brown Melinda buys $6846 in Precision BioSciences (DTIL) - Investing.com

Click here to get full coverage on DTIL Stock: Surge or Bubble? - StocksToTrade

DTIL Stock: Surge or Bubble?  StocksToTrade

DTIL Stock: Surge or Bubble? - StocksToTrade

Click here to get full coverage on A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st

A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy  simplywall.st

A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st

Click here to get full coverage on Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus

Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations  GuruFocus

Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus

Click here to get full coverage on Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL) - Seeking Alpha

Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL)  Seeking Alpha

Precision Biosciences: Still Swinging And Finally Drawing Blood (NASDAQ:DTIL) - Seeking Alpha

Click here to get full coverage on Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance

Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy  Yahoo Finance

Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance

Click here to get full coverage on Industries Limited (DTIL) - Global Market Influence & Discover Top Gainers in Every Sector - bollywoodhelpline.com

Industries Limited (DTIL) - Global Market Influence & Discover Top Gainers in Every Sector  bollywoodhelpline.com

Industries Limited (DTIL) - Global Market Influence & Discover Top Gainers in Every Sector - bollywoodhelpline.com

Click here to get full coverage on $DTIL stock is down 10% today. Here's what we see in our data. - Quiver Quantitative

$DTIL stock is down 10% today. Here's what we see in our data.  Quiver Quantitative

$DTIL stock is down 10% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Insider Buying: Precision BioSciences (NASDAQ:DTIL) Director Acquires $12,690.00 in Stock - MarketBeat

Insider Buying: Precision BioSciences (NASDAQ:DTIL) Director Acquires $12,690.00 in Stock  MarketBeat

Insider Buying: Precision BioSciences (NASDAQ:DTIL) Director Acquires $12,690.00 in Stock - MarketBeat

Click here to get full coverage on Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates  Yahoo Finance

Precision BioSciences (DTIL) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Industries Limited (DTIL) - Price-to-Earnings Ratio Insights & Free High Impact Stock Picks - bollywoodhelpline.com

Industries Limited (DTIL) - Price-to-Earnings Ratio Insights & Free High Impact Stock Picks  bollywoodhelpline.com

Industries Limited (DTIL) - Price-to-Earnings Ratio Insights & Free High Impact Stock Picks - bollywoodhelpline.com

Click here to get full coverage on Precision BioSciences (NASDAQ:DTIL) Director Geno Germano Buys 3,000 Shares - MarketBeat

Precision BioSciences (NASDAQ:DTIL) Director Geno Germano Buys 3,000 Shares  MarketBeat

Precision BioSciences (NASDAQ:DTIL) Director Geno Germano Buys 3,000 Shares - MarketBeat

Click here to get full coverage on Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates  Yahoo Finance

Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on Industries Limited (DTIL) Gets Regulatory Approval - Swing Trading Watchlist & Daily Tips From Top Market Analysts - bollywoodhelpline.com

Industries Limited (DTIL) Gets Regulatory Approval - Swing Trading Watchlist & Daily Tips From Top Market Analysts  bollywoodhelpline.com

Industries Limited (DTIL) Gets Regulatory Approval - Swing Trading Watchlist & Daily Tips From Top Market Analysts - bollywoodhelpline.com

Click here to get full coverage on Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)  Business Wire

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Click here to get full coverage on Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6 - Business Wire

Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6  Business Wire

Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6 - Business Wire

Click here to get full coverage on Precision BioSciences (DTIL) Announces $75 Million Stock Offerin - GuruFocus

Precision BioSciences (DTIL) Announces $75 Million Stock Offerin  GuruFocus

Precision BioSciences (DTIL) Announces $75 Million Stock Offerin - GuruFocus

Click here to get full coverage on Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - Business Wire

Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025  Business Wire

Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - Business Wire

Click here to get full coverage on Showing Safety, Tolerability and Cumulative, Dose-Dependent Antiviral Activity in First Three Cohorts - Business Wire

Showing Safety, Tolerability and Cumulative, Dose-Dependent Antiviral Activity in First Three Cohorts  Business Wire

Showing Safety, Tolerability and Cumulative, Dose-Dependent Antiviral Activity in First Three Cohorts - Business Wire

Click here to get full coverage on Precision BioSciences Announces U.S. Patent Covering PBGENE-HBV for Chronic Hepatitis B and Updates Program Status - Business Wire

Precision BioSciences Announces U.S. Patent Covering PBGENE-HBV for Chronic Hepatitis B and Updates Program Status  Business Wire

Precision BioSciences Announces U.S. Patent Covering PBGENE-HBV for Chronic Hepatitis B and Updates Program Status - Business Wire

Click here to get full coverage on Precision BioSciences Announces Stock Offering and Warrants - TradingView — Track All Markets

Precision BioSciences Announces Stock Offering and Warrants  TradingView — Track All Markets

Precision BioSciences Announces Stock Offering and Warrants - TradingView — Track All Markets

Click here to get full coverage on DTIL Revenue Drops 99% - AOL.com

DTIL Revenue Drops 99% - AOL.com

Click here to get full coverage on Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update  Yahoo Finance

Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

Click here to get full coverage on Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting - Business Wire

Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting  Business Wire

Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting - Business Wire

Click here to get full coverage on DTIL Reports Strong Start to 2025 with Clinical Progress | DTIL Stock News - GuruFocus

DTIL Reports Strong Start to 2025 with Clinical Progress | DTIL Stock News  GuruFocus

DTIL Reports Strong Start to 2025 with Clinical Progress | DTIL Stock News - GuruFocus

Click here to get full coverage on DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up - Yahoo Finance

DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up  Yahoo Finance

DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up - Yahoo Finance

Click here to get full coverage on Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial - Business Wire

Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial  Business Wire

Precision BioSciences Announces Opening of First Clinical Trial Site in U.S. for ELIMINATE-B Trial - Business Wire

Click here to get full coverage on PRECISION BIOSCIENCES Earnings Preview: Recent $DTIL Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

PRECISION BIOSCIENCES Earnings Preview: Recent $DTIL Insider Trading, Hedge Fund Activity, and More  Quiver Quantitative

PRECISION BIOSCIENCES Earnings Preview: Recent $DTIL Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Click here to get full coverage on PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView — Track All Markets

PRECISION BIOSCIENCES INC SEC 10-Q Report  TradingView — Track All Markets

PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView — Track All Markets

Click here to get full coverage on Precision BioSciences raises $75 million in stock and warrant offering - Investing.com

Precision BioSciences raises $75 million in stock and warrant offering  Investing.com

Precision BioSciences raises $75 million in stock and warrant offering - Investing.com

Click here to get full coverage on Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy - Business Wire

Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy  Business Wire

Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy - Business Wire

Click here to get full coverage on Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025 - Business Wire

Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025  Business Wire

Precision BioSciences Announces Presentation of Clinical Data from the ELIMINATE-B Trial at HEP-DART 2025 - Business Wire

Click here to get full coverage on Precision BioSciences launches $75M stock and warrant offering - MSN

Precision BioSciences launches $75M stock and warrant offering  MSN

Precision BioSciences launches $75M stock and warrant offering - MSN

Click here to get full coverage on Precision BioSciences Announces $70M Stock Offering - TipRanks

Precision BioSciences Announces $70M Stock Offering  TipRanks

Precision BioSciences Announces $70M Stock Offering - TipRanks

Click here to get full coverage on Industries Limited (DTIL) Gets Regulatory Approval - Economic Data Impact & High Yield Trading Signals - bollywoodhelpline.com

Industries Limited (DTIL) Gets Regulatory Approval - Economic Data Impact & High Yield Trading Signals  bollywoodhelpline.com

Industries Limited (DTIL) Gets Regulatory Approval - Economic Data Impact & High Yield Trading Signals - bollywoodhelpline.com

Click here to get full coverage on Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)  FinancialContent

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent

Click here to get full coverage on Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL) - Seeking Alpha

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL)  Seeking Alpha

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL) - Seeking Alpha

Click here to get full coverage on Precision BioSciences Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView — Track All Markets

Precision BioSciences Inc reports results for the quarter ended September 30 - Earnings Summary  TradingView — Track All Markets

Precision BioSciences Inc reports results for the quarter ended September 30 - Earnings Summary - TradingView — Track All Markets

Click here to get full coverage on Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B - Business Wire

Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B  Business Wire

Precision BioSciences Announces Phase 1 Safety and Efficacy for Cohort 1, Lowest Dose Level in ELIMINATE-B, a First-In-Human Trial of PBGENE-HBV for Chronic Hepatitis B - Business Wire

Click here to get full coverage on Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants - Legal Desire Media and Insights

Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants  Legal Desire Media and Insights

Latham Represents Precision BioSciences in US$75 Million Offering of Common Stock, Pre-Funded Warrants, and Warrants - Legal Desire Media and Insights

Click here to get full coverage on Precision BioSciences Inc Updates on ELIMINATE-B Clinical Trial - TradingView — Track All Markets

Precision BioSciences Inc Updates on ELIMINATE-B Clinical Trial  TradingView — Track All Markets

Precision BioSciences Inc Updates on ELIMINATE-B Clinical Trial - TradingView — Track All Markets

Click here to get full coverage on Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - 01net

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)  01net

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - 01net

Click here to get full coverage on Precision BioSciences to Report First Quarter 2025 Results on Ma - GuruFocus

Precision BioSciences to Report First Quarter 2025 Results on Ma  GuruFocus

Precision BioSciences to Report First Quarter 2025 Results on Ma - GuruFocus

Click here to get full coverage on Bull Bear: Is DTIL stock trading at a premium valuation - Weekly Trade Review & Low Drawdown Momentum Trade Ideas - moha.gov.vn

Bull Bear: Is DTIL stock trading at a premium valuation - Weekly Trade Review & Low Drawdown Momentum Trade Ideas  moha.gov.vn

Bull Bear: Is DTIL stock trading at a premium valuation - Weekly Trade Review & Low Drawdown Momentum Trade Ideas - moha.gov.vn

Click here to get full coverage on Precision BioSciences Announces Late-Breaking Poster Presentation at the 30 - Business Wire

Precision BioSciences Announces Late-Breaking Poster Presentation at the 30  Business Wire

Precision BioSciences Announces Late-Breaking Poster Presentation at the 30 - Business Wire

Click here to get full coverage on Wall Street Analysts Think Precision BioSciences (DTIL) Could Surge 277.6%: Read This Before Placing a Bet - Yahoo Finance

Wall Street Analysts Think Precision BioSciences (DTIL) Could Surge 277.6%: Read This Before Placing a Bet  Yahoo Finance

Wall Street Analysts Think Precision BioSciences (DTIL) Could Surge 277.6%: Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why - Finviz

TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why  Finviz

TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why - Finviz

Click here to get full coverage on Durham biotech trims staff to extend cash ruwnay - The Business Journals

Durham biotech trims staff to extend cash ruwnay  The Business Journals

Durham biotech trims staff to extend cash ruwnay - The Business Journals

Click here to get full coverage on Precision BioSciences' (DTIL) New Lymphoma Drug IND Gets FDA Nod - Yahoo Finance

Precision BioSciences' (DTIL) New Lymphoma Drug IND Gets FDA Nod  Yahoo Finance

Precision BioSciences' (DTIL) New Lymphoma Drug IND Gets FDA Nod - Yahoo Finance

Click here to get full coverage on Shareholders in Precision BioSciences (NASDAQ:DTIL) have lost 88%, as stock drops 11% this past week - Yahoo Finance

Shareholders in Precision BioSciences (NASDAQ:DTIL) have lost 88%, as stock drops 11% this past week  Yahoo Finance

Shareholders in Precision BioSciences (NASDAQ:DTIL) have lost 88%, as stock drops 11% this past week - Yahoo Finance

Click here to get full coverage on DTIL - Precision Biosciences Latest Stock News & Market Updates - Stock Titan

DTIL - Precision Biosciences Latest Stock News & Market Updates  Stock Titan

DTIL - Precision Biosciences Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Precision BioSciences (DTIL) - Zacks Investment Research

Precision BioSciences (DTIL)  Zacks Investment Research

Precision BioSciences (DTIL) - Zacks Investment Research

Click here to get full coverage on Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength? - Yahoo Finance

Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength?  Yahoo Finance

Strength Seen in Precision BioSciences (DTIL): Can Its 20.4% Jump Turn into More Strength? - Yahoo Finance

Click here to get full coverage on H.C. Wainwright Maintains Buy on Precision BioSciences Stock By Investing.com - Investing.com UK

H.C. Wainwright Maintains Buy on Precision BioSciences Stock By Investing.com  Investing.com UK

H.C. Wainwright Maintains Buy on Precision BioSciences Stock By Investing.com - Investing.com UK

Click here to get full coverage on Dhunseri Tea & Industries Approves USD 1 Million Debenture Subscription in Subsidiary - scanx.trade

Dhunseri Tea & Industries Approves USD 1 Million Debenture Subscription in Subsidiary  scanx.trade

Dhunseri Tea & Industries Approves USD 1 Million Debenture Subscription in Subsidiary - scanx.trade

Click here to get full coverage on DTIL Stock Price and Chart — NASDAQ:DTIL - TradingView — Track All Markets

DTIL Stock Price and Chart — NASDAQ:DTIL  TradingView — Track All Markets

DTIL Stock Price and Chart — NASDAQ:DTIL - TradingView — Track All Markets

Click here to get full coverage on Precision BioSciences, Inc. (NASDAQ:DTIL) insiders recover some losses but still US$21k away from matching original investment - Yahoo Finance

Precision BioSciences, Inc. (NASDAQ:DTIL) insiders recover some losses but still US$21k away from matching original investment  Yahoo Finance

Precision BioSciences, Inc. (NASDAQ:DTIL) insiders recover some losses but still US$21k away from matching original investment - Yahoo Finance

Click here to get full coverage on Dhunseri Tea & Industries Receives Credit Rating Reaffirmation from CARE Ratings - scanx.trade

Dhunseri Tea & Industries Receives Credit Rating Reaffirmation from CARE Ratings  scanx.trade

Dhunseri Tea & Industries Receives Credit Rating Reaffirmation from CARE Ratings - scanx.trade

Click here to get full coverage on Precision BioSciences (DTIL) Stock Price, News & Analysis - MarketBeat

Precision BioSciences (DTIL) Stock Price, News & Analysis  MarketBeat

Precision BioSciences (DTIL) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Dhunseri Tea & Industries Finalizes Sale of Deohall Tea Estate - scanx.trade

Dhunseri Tea & Industries Finalizes Sale of Deohall Tea Estate  scanx.trade

Dhunseri Tea & Industries Finalizes Sale of Deohall Tea Estate - scanx.trade

Click here to get full coverage on Precision Biosciences: Plenty Of Positive Updates; Waiting For The Market To Notice (DTIL) - Seeking Alpha

Precision Biosciences: Plenty Of Positive Updates; Waiting For The Market To Notice (DTIL)  Seeking Alpha

Precision Biosciences: Plenty Of Positive Updates; Waiting For The Market To Notice (DTIL) - Seeking Alpha

Click here to get full coverage on Precision BioSciences Appoints Juli Blanche as Chief People Officer - Quantisnow

Precision BioSciences Appoints Juli Blanche as Chief People Officer  Quantisnow

DTIL

Price Chart

Key Statistics

Technicals

About DTIL

Latest News

Short Interest in Precision BioSciences, Inc. (NASDAQ:DTIL) Expands By 27.4% - MarketBeat

Industries Limited (DTIL) Quarterly Results Are Out - Federal Reserve Announcements & Fast Growing Investment Ideas - bollywoodhelpline.com

Precision BioSciences: Potential Proof-Of-Concept Data For HBV Cure In 2026 (NASDAQ:DTIL) - Seeking Alpha

Advanced Charts

Top Gainers

Top Losers